undamentalytics Newsletter

Irulya Therapeutics Inc.: which funds bought and sold

Institutions that bought and sold Irulya Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.

Between March 31, 2026 and June 30, 2026, 24 institutions that filed 13F reports for both quarters added to or opened positions in Irulya Therapeutics, and 0 cut or closed them. Together they added a net 260K shares, — on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 90K shares; index fund managers were net buyers of 17K shares. 24 opened a new position and 0 sold out entirely.

Bought, Q2 2026 24 institutions, 24 of them new holders Sold, Q2 2026 0 institutions, 0 of them sold out
Net change, all compared +260K shares (—)
Net change, active managers +90K shares (—), 3 bought, 0 sold

Buyers versus sellers

institutions compared, 24
Active managers and hedge funds 3 bought · 0 sold · +90K
Index fund managers 3 bought · 0 sold · +17K
Other institutions 18 bought · 0 sold · +153K

Biggest buyers

by change in shares held
Biggest buyers
Institution Change in shares Shares June 30, 2026 Value
Ikarian Capital, LLC +72K New position 72K $1.3M
Millennium Management LLC Hedge fund +71K New position 71K $1.3M
Squadron Capital Management LLC +40K New position 40K $734,421
Shay Capital LLC +17K New position 17K $329,272
Boothbay Fund Management, LLC Hedge fund +14K New position 14K $253,041
Jane Street Group, LLC +13K New position 13K $229,958
Vanguard Capital Management LLC Index funds +12K New position 12K $219,080
Cormorant Asset Management, LP Hedge fund +5,498 New position 5,498 $100,009
UBS Group AG +4,730 New position 4,730 $86,039
Morgan Stanley +4,084 New position 4,084 $74,288
Vanguard Fiduciary Trust Co Index funds +3,614 New position 3,614 $65,739
Blackrock, Inc. Index funds +1,702 New position 1,702 $30,959
Tower Research Capital LLC (TRC) +567 New position 567 $10,314
Gen-Wealth Partners Inc +165 New position 165 $3,001
Operose Advisors LLC +159 New position 159 $2,893
Fortitude Family Office, LLC +40 New position 40 $728
Barclays PLC +27 New position 27 $491
Integrated Wealth Concepts LLC +12 New position 12 $218
Wells Fargo & Company +10 New position 10 $182
Allworth Financial LP +8 New position 8 $137

Biggest sellers

by change in shares held
Biggest sellers
Institution Change in shares Shares June 30, 2026 Value
No institution cut its holding.

New positions

largest by value
InstitutionSharesValue June 30, 2026
Ikarian Capital, LLC 72K $1.3M
Millennium Management LLCHedge fund 71K $1.3M
Squadron Capital Management LLC 40K $734,421
Shay Capital LLC 17K $329,272
Boothbay Fund Management, LLCHedge fund 14K $253,041
Jane Street Group, LLC 13K $229,958
Vanguard Capital Management LLCIndex funds 12K $219,080
Cormorant Asset Management, LPHedge fund 5,498 $100,009
UBS Group AG 4,730 $86,039
Morgan Stanley 4,084 $74,288

Sold out

largest by value
InstitutionSharesValue March 31, 2026
No institution sold its whole holding.

Who holds the shares

13F holdings at June 30, 2026
Institutions reporting
24
Ten largest holders
97.6%
of 13F-reported shares
Index fund managers
6.7%
of 13F-reported shares
Active managers and hedge funds
34.7%
of 13F-reported shares
Buying and selling by type of institution, March 31, 2026 to June 30, 2026
TypeBoughtSoldNewSold outNet change in sharesNet %
Active managers and hedge funds 3 0 3 0 +90K —
Index fund managers 3 0 3 0 +17K —
Other institutions 18 0 18 0 +153K —

Active managers and hedge funds: a list we maintain of about 400 well-known stock-picking firms and hedge funds, matched by SEC registration number (CIK) and checked against the filer names each quarter. Index fund managers: the large index houses, such as BlackRock, Vanguard, State Street, Geode and Northern Trust. Every other filer (banks, brokers, wealth managers, pension funds, insurers and firms not on the list) counts as another institution. A firm that files under several SEC registrations appears once for each.

← Back to Irulya Therapeutics Inc. · Insiders · Politicians